Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

As the global supply chain has begun to slowly untangle itself over the past few months, ResMed has finally been able to scale up production of its sleep apnea hardware and start to fill the massive ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

ResMed is a dominant player in healthcare devices with strong margins, recurring revenues, and a near-monopoly, offering a compelling mix of value and growth. The company continually invests in R&D, ...

Resmed RMD has received FDA clearance for Personalized Therapy Comfort Settings (“PTCS”), which will be marketed as Smart Comfort. The company will debut Smart Comfort in early 2026 in a limited U.S.

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea. The NightOwl testing device, about the size of a quarter, is worn on the user ...

Add articles to your saved list and come back to them any time. Medical devices giant Resmed has been hit with a major patent infringement claim by the prestigious New York University, which alleges ...

Due to a shortage of lifesaving breathing machines amid the COVID-19 (coronavirus) pandemic, the U.S. Food and Drug Administration (FDA) issued guidelines last month that allow hospitals, universities ...